CN: 32-1845/R
ISSN: 2095-6975
Cite this paper:
LI Zheng, CHEN Qian-Qian, LAM Christopher Wai Kei, GUO Jian-Ru, ZHANG Wei-Jia, WANG Cai-Yun, WONG Vincent Kam Wai, YAO Mei-Cun, ZHANG Wei. Investigation into perturbed nucleoside metabolism and cell cycle for elucidating the cytotoxicity effect of resveratrol on human lung adenocarcinoma epithelial cells[J]. Chinese Journal of Natural Medicines, 2019, 17(8): 608-615

Investigation into perturbed nucleoside metabolism and cell cycle for elucidating the cytotoxicity effect of resveratrol on human lung adenocarcinoma epithelial cells

LI Zheng1, CHEN Qian-Qian1, LAM Christopher Wai Kei2, GUO Jian-Ru1, ZHANG Wei-Jia3, WANG Cai-Yun1, WONG Vincent Kam Wai1, YAO Mei-Cun3, ZHANG Wei1
1 State Key Laboratory of Quality Research in Chinese Medicines and Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macau 999078, China;
2 Faculty of Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macau 999078, China;
3 School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China
In an effort to understand the molecular events contributing to the cytotoxicity activity of resveratrol (RSV), we investigated its effects on human lung adenocarcinoma epithelial cell line A549 at different concentrations. Cellular nucleoside metabolic profiling was determined by an established liquid chromatography-mass spectrometry method in A549 cells. RSV resulted in significant decreases and imbalances of deoxyribonucleoside triphosphates (dNTPs) pools suppressing subsequent DNA synthesis. Mean-while, RSV at high concentration caused significant cell cycle arrest at S phase, in which cells required the highest dNTPs supply than other phases for DNA replication. The inhibition of DNA synthesis thus blocked subsequent progression through S phase in A549 cells, which may partly contribute to the cytotoxicity effect of RSV. However, hydroxyurea (HU), an inhibitor of RNR activity, caused similar dNTPs perturbation but no S phase arrest, finally no cytotoxicity effect. Therefore, we believed that the dual effect of high concentration RSV, including S phase arrest and DNA synthesis inhibition, was required for its cytotoxicity effect on A549 cells. In summary, our results provided important clues to the molecular basis for the anticancer effect of RSV on epithelial cells.
Key words:    Resveratrol    LC-MS    Deoxyribonucleotides    DNA synthesis    S phase arrest   
Received: 2019-05-13   Revised:
PDF (1482 KB) Free
Print this page
Email this article to others
Articles by LI Zheng
Articles by CHEN Qian-Qian
Articles by LAM Christopher Wai Kei
Articles by GUO Jian-Ru
Articles by ZHANG Wei-Jia
Articles by WANG Cai-Yun
Articles by WONG Vincent Kam Wai
Articles by YAO Mei-Cun
Articles by ZHANG Wei
[1] Baur JA, Sinclair DA. Therapeutic potential of resveratrol:the in vivo evidence[J]. Nat Rev Drug Discov, 2006, 5(6):493-506.
[2] Pirola L, Fröjdö S. Resveratrol:one molecule, many tar-gets[J]. IUBMB Life, 2008, 60(5):323-332.
[3] Li H, Xia N, Förstermann U. Cardiovascular effects and molecular targets of resveratrol[J]. Nitric oxide, 2012, 26(2):102-110.
[4] Jang JY, Min JH, Wang SB, et al. Resveratrol inhibits collagen-induced platelet stimulation through suppressing NADPH oxidase and oxidative inactivation of SH2 domain-containing protein tyrosine phosphatase-2[J]. Free Radical Bio Med, 2015, 89:842-851.
[5] Valdecantos MP, Pérez-Matute P, Quintero P, et al. Vitamin C, resveratrol and lipoic acid actions on isolated rat liver mitochondria:all antioxidants but different[J]. Redox Rep, 2010, 15(5):207-216.
[6] Tung BT, Rodríguez-Bies E, Talero E, et al. Anti-inflammatory effect of resveratrol in old mice liver[J]. Exp Gerontol, 2015, 64:1-7.
[7] Varshney P, Dey CS. Resveratrol regulates neuronal glucose uptake and insulin sensitivity via P21-activated kinase 2(PAK2)[J]. Biochem Bioph Res Co, 2017, 485(2):372-378.
[8] Sadi G, Bozan D, Yildiz HB. Redox regulation of antioxi-dant enzymes:post-translational modulation of catalase and glutathione peroxidase activity by resveratrol in diabetic rat liver[J]. Mol Cell Biochem, 2014, 393(1-2):111-122.
[9] Kuršvietienė L, Stanevičienė I, Mongirdienė A, et al. Multiplicity of effects and health benefits of resveratrol[J]. Medicina, 2016, 52(3):148-155.
[10] Gwak HR, Kim S, Dhanasekaran DN, et al. Resveratrol triggers ER stress-mediated apoptosis by disrupting N-linked glycosylation of proteins in ovarian cancer cells[J]. Cancer Lett, 2016, 371(2):347-353.
[11] Selvaraj S, Sun Y, Sukumaran P, et al. Resveratrol acti-vates autophagic cell death in prostate cancer cells via downregulation of STIM1 and the mTOR pathway[J]. Mol Carcinogen, 2016, 55(5):818-831.
[12] Alayev A, Salamon RS, Schwartz NS, et al. Combination of rapamycin and resveratrol for treatment of bladder cancer[J]. J Cell Physiol, 2017, 232(2):436-446.
[13] Rauf A, Imran M, Butt MS, et al. Resveratrol as an anti-cancer agent:A review[J]. Crit Rev Food Sci, 2018, 58(9):1428-1447.
[14] Fontecave M, Lepoivre M, Elleingand E, et al. Resveratrol, a remarkable inhibitor of ribonucleotide reductase[J]. FEBS Lett, 1998, 421(3):277-279.
[15] Subbaramaiah K, Chung WJ, Michaluart P, et al. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells[J]. J Biol Chem, 1998, 273(34):21875-21882.
[16] Szekeres T, Saiko P, Fritzer-Szekeres M, et al. Chemopreventive effects of resveratrol and resveratrol derivatives[J]. Ann NY Acad Sci, 2011, 1215(1):89-95.
[17] Crona M, Codó P, Jonna VR, et al. A ribonucleotide re-ductase inhibitor with deoxyribonucleoside-reversible cytotoxicity[J]. Mol Oncol, 2016, 10(9):1375-1386.
[18] Mah V, Alavi M, Márquez-Garbán DC, et al. Ribonucleo-tide reductase subunit M2 predicts survival in subgroups of patients with non-small cell lung carcinoma:effects of gender and smoking status[J]. PLoS One, 2015, 10(5):e0127600.
[19] Elford HL, Freese M, Passamani E, et al. Ribonucleotide reductase and cell proliferation. I. Variations of ribonucleotide reductase activity with tumor growth rate in a series of rat hepatomas[J]. J Biol Chem, 1970, 245(20):5228-5233.
[20] Zhang W, Tan S, Paintsil E, et al. Analysis of deoxyribonucleotide pools in human cancer cell lines using a liquid chromatography coupled with tandem mass spectrometry technique[J]. Biochem Pharmacol, 2011, 82(4):411-417.
[21] Zegerman P, Diffley JF. DNA replication as a target of the DNA damage checkpoint[J]. DNA Repair, 2009, 8(9):1077-1088.
[22] Pai CC, Kearsey S. A critical balance:dNTPs and the maintenance of genome stability[J]. Genes, 2017, 8(2):57.
[23] Varoni EM, Lo Faro AF, Sharifi-Rad J, et al. Anticancer molecular mechanisms of resveratrol[J]. Front Nutr, 2016, 3:8.
[24] Yuan L, Zhang Y, Xia J, et al. Resveratrol induces cell cycle arrest via a p53-independent pathway in A549 cells[J]. Mol Med Rep, 2015, 11(4):2459-2464.
[25] Bai Y, Mao QQ, Qin J, et al. Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo[J]. Cancer Sci, 2010, 101(2):488-493.
[26] Cui J, Sun R, Yu Y, et al. Antiproliferative effect of res-veratrol in pancreatic cancer cells[J]. Phytother Res, 2010, 24(11):1637-1644.
[27] Delmas D, Lançon A, Colin D, et al. Resveratrol as a chemopreventive agent:a promising molecule for fighting cancer[J]. Curr Drug Targets, 2006, 7(4):423-442.
[28] Fulda S, Debatin KM. Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol[J]. Cancer Res, 2004, 64(1):337-346.
[29] Castello L, Tessitore L. Resveratrol inhibits cell cycle progression in U937 cells[J]. Oncol Rep, 2005, 13(1):133-138.
[30] Yu XM, Jaskula-Sztul R, Ahmed K, et al. Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth[J]. Mol Cancer Ther, 2013, 12(7):1276-1287.
[31] Whyte L, Huang YY, Torres K, et al. Molecular mecha-nisms of resveratrol action in lung cancer cells using dual protein and microarray analyses[J]. Cancer Res, 2007, 67(24):12007-12017.
[32] Gu S, Chen C, Jiang X, et al. ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction underlie apoptosis induced by resveratrol and arsenic trioxide in A549 cells[J]. Chem-Biol Interact, 2016, 245:100-109.
[33] Kim Y, Lee WH, Choi TH, et al. Involvement of p21WAF1/CIP1, pRB, Bax and NF-κB in induction of growth arrest and apoptosis by resveratrol in human lung carcinoma A549 cells[J]. Int J Oncol, 2003, 23(4):1143-1149.
[34] Liao HF, Kuo CD, Yang YC, et al. Resveratrol enhances radiosensitivity of human non-small cell lung cancer NCI-H838 cells accompanied by inhibition of nuclear factor-kappa B activation[J]. J Radiat Res, 2005, 46(4):387-393.
[35] Kaminski MB, Steinhilber DM Stein J, et al. Phytochemi-cals resveratrol and sulforaphane as potential agents for enhancing the anti-tumor activities of conventional cancer therapies[J]. Curr Pharm Biotechno, 2012, 13(1):137-146.
[36] Fontecave M, Lepoivre M, Elleingand E, et al. Resveratrol, a remarkable inhibitor of ribonucleotide reductase[J]. FEBS Lett, 1998, 421(3):277-279.
[37] Szekeres T, Fritzer-Szekeres M, Saiko P, et al. Resveratrol and resveratrol analogues-structure-activity relationship[J]. Pharm Res, 2010, 27(6):1042-1048.
[38] Saban N, Bujak M. Hydroxyurea and hydroxamic acid derivatives as antitumor drugs[J]. Cancer Chemoth Pharm, 2009, 64(2):213.
[39] Osterman Golkar S, Czene S, Gokarakonda A, et al. Intracellular deoxyribonucleotide pool imbalance and DNA damage in cells treated with hydroxyurea, an inhibitor of ribonucleotide reductase[J]. Mutagenesis, 2013, 28(6):653-660.